• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » NMT Medical narrows Q3 net loss despite top-line slide

NMT Medical narrows Q3 net loss despite top-line slide

October 29, 2009 By MassDevice staff

NMT Medical Inc. cut its third-quarter net loss by more than 34 percent despite posting a revenue decline of nearly 28 percent and announced a new distribution deal in Germany

The Boston-based cardiac implant maker reported sales of $3 million for the three months ended Spet. 30, down 27.7 percent compared with $4.2 million during the same period last year.

Net losses narrowed from $4.4 million during Q3 2008 to $2.9 million during the just-ended period, as NMT slashed its total expenses by 31 percent to $5.9 million. As a percentage of revenues, total expenses dropped 9.3 percent.

President and CEO Frank Martin said the revenue slide was expected, given the state of the global economy and the impact of lower hospital inventories. NMT is also moving from a direct sales business model outside of North America, to a distribution model.

Martin said the company inked a distribution deal in Germany with Nicolai, a division of Spanish healthcare distribution conglomerate Werfen Group.

“We currently plan to continue executing this distribution strategy in a number of overseas markets in order to capitalize on these territories,” Martin said.

NMT pushed up the scheduling of its Closure I clinical trial during the quarter. The company said it plans to begin analyzing the data from the study of its StarFlex cardiac implant in April of next year, ahead of its fall 2010 target date.

Martin said that means NMT could submit a pre-market approval application to the Food & Drug Administration during the third quarter of 2010, assuming positive results from Closure I.

COO Richard Davis said the company expects full-year sales of $13 million to $14 million for the full year 2009.

Filed Under: Business/Financial News, Implants, MassDevice Earnings Roundup

More recent news

  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy